Cargando…

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer

Circular RNA (circRNA) is considered to be an important regulator that mediates cancer chemoresistance. But whether circ-LPAR3 is involved in ovarian cancer (OC) cisplatin (DDP) resistance is unclear. The circ-LPAR3, miR-634 and pyruvate dehydrogenase kinase 1 (PDK1) expression was measured by quant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuemei, Yin, Zhiping, Wu, Yanjun, Zhan, Qian, Huang, Honghong, Fan, Jiangtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974081/ https://www.ncbi.nlm.nih.gov/pubmed/35081867 http://dx.doi.org/10.1080/21655979.2022.2029109

Ejemplares similares

Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells
por: Zuckerman, Valentina, et al.
Publicado: (2015)

Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
por: He, Jian, et al.
Publicado: (2021)

Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5
por: Lei, Li, et al.
Publicado: (2021)

A Novel Function of the Lysophosphatidic Acid Receptor 3 (LPAR3) Gene in Zebrafish on Modulating Anxiety, Circadian Rhythm Locomotor Activity, and Short-Term Memory
por: Lin, Yu-Nung, et al.
Publicado: (2020)

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
por: Takagi, Satoshi, et al.
Publicado: (2021)

HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells
por: Kim, Nam-Ho, et al.
Publicado: (2019)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis
por: Shi, Yijun, et al.
Publicado: (2020)

Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
por: Wu, Cheng-Yong, et al.
Publicado: (2020)

Circular RNA circLPAR3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Upregulating HMGB1 via Sponging miR-375/miR-433
por: Cheng, Hongzhong, et al.
Publicado: (2020)

Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway
por: Kim, Donghee, et al.
Publicado: (2021)

Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction
por: Zheng, Rui, et al.
Publicado: (2022)

Lysophosphatidic Acid Promotes Epithelial–Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy
por: Lee, Geon-Ho, et al.
Publicado: (2022)

Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
por: Su, Zhijian, et al.
Publicado: (2022)

Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study
por: Younis, Saima, et al.
Publicado: (2017)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)

Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways
por: Onallah, Hadil, et al.
Publicado: (2019)

Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis: hsa_circ_0007444/miR-23a-3p/DICER1 in ovarian cancer
por: Zhang, Min, et al.
Publicado: (2023)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells
por: Sui, Yanxia, et al.
Publicado: (2015)

AP003352.1/miR-141-3p axis enhances the proliferation of osteosarcoma by LPAR3
por: Yu, Hongde, et al.
Publicado: (2023)

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)

An LPAR(5)-antagonist that reduces nociception and increases pruriception
por: Langedijk, Jacqueline, et al.
Publicado: (2022)

microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness
por: Jeong, Bo Young, et al.
Publicado: (2021)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)

Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
por: Brusevold, Ingvild J, et al.
Publicado: (2014)

Circular RNA circVAMP3 promotes aerobic glycolysis and proliferation by regulating LDHA in renal cell carcinoma
por: Li, Jun, et al.
Publicado: (2022)

The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Exosomal circLPAR1 Promoted Osteogenic Differentiation of Homotypic Dental Pulp Stem Cells by Competitively Binding to hsa-miR-31
por: Xie, Liangkun, et al.
Publicado: (2020)

Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer
por: Yang, Fan, et al.
Publicado: (2017)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Paradoxical downregulation of LPAR3 exerts tumor-promoting activity through autophagy induction in Ras-transformed cells
por: Hwang, Sung-Hee, et al.
Publicado: (2022)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer
por: Meshcheryakova, Anastasia, et al.
Publicado: (2019)

Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
por: Kritikou, Eva, et al.
Publicado: (2016)

circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
por: Shi, Wenting, et al.
Publicado: (2022)

Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line
por: Rivera, Richard, et al.
Publicado: (2021)

Reduction of LPAR1 Expression in Neuroblastoma Promotes Tumor Cell Migration
por: Liu, Xiangjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_18iv4o68hr25qnnll829grsaov